Clinical Trial Update: Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Truvada alone versus Truvada plus hepatitis B immunoglobulin (HBIg) to prevent recurrence of chronic hepatitis B after liver transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B immunoglobulin (HBIg) (hepatitis B immunoglobulin)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2013-09-19